<html>
<head><title>
Prepared and filed by St Ives Financial
</title>
</head>
<page>
<body bgcolor="#FFFFFF"> <p align="center"><font size="2" face="serif">SECURITIES AND EXCHANGE COMMISSION<br>WASHINGTON, D.C. 20549</font></p>
<hr align="center" width="20%" size="1" noshade>
<p align="center"><font size="2" face="serif">FORM 8-K</font></p>
<p align="center"><font size="2" face="serif">CURRENT REPORT<br>PURSUANT TO SECTION 13 OR 15(d) OF<br>THE SECURITIES EXCHANGE ACT OF 1934</font></p>
<p align="center"><font size="2" face="serif">Date of Report (Date of earliest event reported):  March 30, 2006</font></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
  <tr valign="bottom">
    <td colspan="3" align="center"><font size="2" face="serif">Savient Pharmaceuticals, Inc.</font><font size="2">&nbsp;</font></td>
  </tr>
  <tr valign="bottom">
    <td colspan="3" align="center"><hr size="1" noshade></td>
  </tr>
  <tr valign="bottom">
    <td colspan="3" align="center"><font size="2">&nbsp;</font><font size="2" face="serif">(Exact name of registrant as specified in
    charter)</font></td>
  </tr>
  <tr valign="bottom">
    <td align="center"><font size="2">&nbsp;</font></td>
    <td width="35%" align="center"><font size="2">&nbsp;</font></td>
    <td align="center">&nbsp;</td>
  </tr>
  <tr valign="bottom">
    <td align="center"><font size="2" face="serif">Delaware</font></td>
    <td align="center"><font size="2" face="serif">0-15313</font></td>
    <td align="center"><font size="2" face="serif">13-3033811</font></td>
  </tr>
  <tr valign="bottom">
    <td colspan="3" align="center"><hr size="1" noshade>
    </td>
  </tr>
  <tr valign="bottom">
    <td align="center"><font size="2" face="serif">(State or other jurisdiction
        of incorporation)</font></td>
    <td align="center"><font size="2" face="serif">(Commission File Number)</font></td>
    <td align="center"><font size="2" face="serif">(IRS Employer Identification No.)</font></td>
  </tr>
  <tr valign="bottom">
    <td align="center"><font size="2">&nbsp;</font></td>
    <td align="center"><font size="2">&nbsp;</font></td>
    <td align="center">&nbsp;</td>
  </tr>
  <tr valign="bottom">
    <td align="center"><font size="2">&nbsp;</font></td>
    <td align="center"><font size="2">&nbsp;</font></td>
    <td align="center">&nbsp;</td>
  </tr>
  <tr valign="bottom">
    <td colspan="3" align="center"><font size="2">&nbsp;</font><font size="2" face="serif">One Tower Center, 14th Floor</font></td>
  </tr>
  <tr valign="bottom">
    <td colspan="3" align="center"><font size="2">&nbsp;</font><font size="2" face="serif">East Brunswick, New Jersey 08816</font></td>
  </tr>
  <tr valign="bottom">
    <td colspan="3" align="center"><hr size="1" noshade></td>
  </tr>
  <tr valign="bottom">
    <td colspan="3" align="center"><font size="2" face="serif">(Address of principal executive offices)
    (Zip Code)</font></td>
  </tr>
  <tr valign="bottom">
    <td align="center"><font size="2">&nbsp;</font></td>
    <td align="center"><font size="2">&nbsp;</font></td>
    <td align="center">&nbsp;</td>
  </tr>
  <tr valign="bottom">
    <td colspan="3" align="center"><font size="2">&nbsp;</font><font size="2" face="serif">Registrant&#8217;s telephone number, including
    area code: (732) 418-9300</font></td>
  </tr>
  <tr valign="bottom">
    <td align="center"><font size="2">&nbsp;</font></td>
    <td align="center"><font size="2">&nbsp;</font></td>
    <td align="center">&nbsp;</td>
  </tr>
  <tr valign="bottom">
    <td colspan="3" align="center"><font size="2">&nbsp;</font><font size="2" face="serif">Not applicable</font></td>
  </tr>
  <tr valign="bottom">
    <td colspan="3" align="center"><hr size="1" noshade>
    </td>
  </tr>
  <tr valign="bottom">
    <td colspan="3" align="center"><font size="2">&nbsp;</font><font size="2" face="serif">(Former name or former address, if changed
    since last report)</font></td>
  </tr>
</table>
<div style="text-indent: 3%"><p align="left"><font size="2" face="serif">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the obligation of the registrant under any of the following provisions:</font></p>
</div>
<table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top">
<td width="3%"><font size="2" face="serif">&nbsp;<img src="emptybox.gif">&nbsp;</font></td>
<td align="left"><font size="2" face="serif">Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></td>
</tr>
</table>
<table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top">
  <td>&nbsp;</td>
  <td align="left">&nbsp;</td>
</tr>
<tr valign="top">
<td width="3%"><font size="2" face="serif">&nbsp;<img src="emptybox.gif" width="12" height="12"></font></td>
<td align="left"><font size="2" face="serif">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></td>
</tr>
</table>
<table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top">
  <td>&nbsp;</td>
  <td align="left">&nbsp;</td>
</tr>
<tr valign="top">
<td width="3%"><font size="2" face="serif">&nbsp;<img src="emptybox.gif"></font></td>
<td align="left"><font size="2" face="serif">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2{b))</font></td>
</tr>
</table>
<table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top">
  <td>&nbsp;</td>
  <td align="left">&nbsp;</td>
</tr>
<tr valign="top">
<td width="3%"><font size="2" face="serif">&nbsp;<img src="emptybox.gif"></font></td>
<td align="left"><font size="2" face="serif">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font></td>
</tr>
</table>
<p align="center"><font face="serif" size="2">&nbsp;</font></p>
<hr noshade align="center" width="100%" size="2">
<div style="page-break-before:always"></div>
<page>
<p align="left"><font size="2" face="serif"><b>Item 2.02.  Results of Operations and Financial Condition</b></font></p>
<div style="text-indent: 3%"><p align="left"><font size="2" face="serif">On March 30, 2006, Savient Pharmaceuticals, Inc. (the &#8220;Registrant&#8221;) announced its financial results for the quarter and fiscal year ended December 31, 2005.  The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K.</font></p>
<p align="left"><font size="2" face="serif">In addition, on March 30, 2006, the Registrant held a publicly available live webcast discussion of its financial results for the quarter and fiscal year ended December 31, 2005.  The transcript of the March 30, 2006 conference call is furnished as Exhibit 99.2 to this Current Report on Form 8-K.</font></p>
</div>
<p align="left"><font size="2" face="serif"><b>Item 9.01.  Financial Statements and Exhibits</b></font></p>
<p align="left"><font size="2" face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Exhibits</font></p>
<table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top">
<td width="3%"><font size="2" face="serif">&nbsp;</font></td>
<td width="3%"><font size="2" face="serif">&nbsp;</font></td>
<td width="3%"><font size="2" face="serif">&nbsp;</font></td>
<td align="left"><font size="2" face="serif">See Exhibit Index attached hereto.</font></td>
</tr>
</table>
<p align="center"><font face="serif" size="2">&nbsp;</font></p>
<hr noshade align="center" width="100%" size="2">
<div style="page-break-before:always"></div>
<page>
<p align="center"><font size="2" face="serif">SIGNATURE</font></p>
<div style="text-indent: 3%"><p align="left"><font size="2" face="serif">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font></p>
</div>
<table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top"> <td align="left"><font size="1" face="serif">&nbsp;</font></td>
<td colspan="2" align="left"><font size="2" face="serif">SAVIENT PHARMACEUTICALS, INC.</font></td> </tr>
<tr valign="top">
  <td align="left">&nbsp;</td>
  <td colspan="2" align="left">&nbsp;</td>
</tr>
<tr valign="top">
<td align="left"><font size="2" face="serif">Date:  April 3, 2006</font></td>
<td colspan="2" align="left"><font size="2" face="serif">By:   <u>/s/ Philip K. Yachmetz</u></font></td>
</tr>
<tr valign="top">
<td colspan="2" align="left"><font size="2" face="serif">&nbsp;</font></td>
<td align="left"><font size="2" face="serif">Philip K. Yachmetz<br>Executive Vice President &amp; <br>Chief Business Officer</font></td>
</tr>
</table>
<p align="center"><font face="serif" size="2">&nbsp;</font></p>
<hr noshade align="center" width="100%" size="2">
<div style="page-break-before:always"></div>
<page>
<p align="center"><font size="2" face="serif">EXHIBIT INDEX</font></p>
<table width="100%" cellspacing="0" cellpadding="0" align="center" border="0">
<tr valign="top" bgcolor="#FFFFFF">
<td align="left"><font size="2" face="serif"><u>Exhibit No.</u></font></td>
<td width="1%" align="right">&nbsp;</td>
<td width="59%" align="left"><font size="2" face="serif"><u>Description</u></font></td>
<td width="2%" align="left">&nbsp;</td> </tr>
<tr valign="top">
<td></td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td></td>
</tr>
<tr valign="top" bgcolor="#ffffff">
<td align="left"><font size="2" face="serif">99.1</font></td>
<td align="right">&nbsp;</td>
<td align="left"><font size="2" face="serif">Press release dated March 30, 2006</font></td>
<td align="left">&nbsp;</td>
</tr>
<tr valign="top" bgcolor="#FFFFFF">
<td align="left"><font size="2" face="serif">99.2</font></td>
<td align="right">&nbsp;</td>
<td align="left"><font size="2" face="serif">Transcript dated March 30, 2006</font></td>
<td align="left">&nbsp;</td>
</tr>
</table>
<p align="center"><font face="serif" size="2">&nbsp;</font></p>
<hr noshade align="center" width="100%" size="2">
</body>
</html>
[{"type": "8-K", "sequence": "1", "filename": "b412552_8k.htm", "description": "CURRENT REPORT", "secsgml_size_bytes": 10099}]
{"company-data": {"conformed-name": "SAVIENT PHARMACEUTICALS INC", "cik": "0000722104", "assigned-sic": "2833", "irs-number": "133033811", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-15313", "film-number": "06734023"}, "business-address": {"street1": "ONE TOWER CENTER", "city": "EAST BRUNSWICK", "state": "NJ", "zip": "08816", "phone": "7324189300"}, "mail-address": {"street1": "ONE TOWER CENTER", "city": "EAST BRUNSWICK", "state": "NJ", "zip": "08816"}, "former-company": {"former-conformed-name": "BIO TECHNOLOGY GENERAL CORP", "date-changed": "19920703"}}
Prepared and filed by St Ives Financial
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):  March 30, 2006
Savient Pharmaceuticals, Inc.
(Exact name of registrant as specified in
    charter)
Delaware
0-15313
13-3033811
(State or other jurisdiction
        of incorporation)
(Commission File Number)
(IRS Employer Identification No.)
One Tower Center, 14th Floor
East Brunswick, New Jersey 08816
(Address of principal executive offices)
    (Zip Code)
Registrant's telephone number, including
    area code: (732) 418-9300
Not applicable
(Former name or former address, if changed
    since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the obligation of the registrant under any of the following provisions:
Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2{b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02.  Results of Operations and Financial Condition
On March 30, 2006, Savient Pharmaceuticals, Inc. (the "Registrant") announced its financial results for the quarter and fiscal year ended December 31, 2005.  The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
In addition, on March 30, 2006, the Registrant held a publicly available live webcast discussion of its financial results for the quarter and fiscal year ended December 31, 2005.  The transcript of the March 30, 2006 conference call is furnished as Exhibit 99.2 to this Current Report on Form 8-K.
Item 9.01.  Financial Statements and Exhibits
(d)      Exhibits
See Exhibit Index attached hereto.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
SAVIENT PHARMACEUTICALS, INC.
Date:  April 3, 2006
By:
/s/ Philip K. Yachmetz
Philip K. Yachmetz
Executive Vice President &
Chief Business Officer
EXHIBIT INDEX
Exhibit No.
Description
99.1
Press release dated March 30, 2006
99.2
Transcript dated March 30, 2006